1. Home
  2. Pharma & Healthcare
  3. Global Biotherapeutics Cell Line Development Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Global Biotherapeutics Cell Line Development Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Publication Month: Feb 2020 | No. of Pages: 103 Published By: Global Info Research
Single User License: US $ 3480
Corporate User License: US $ 6960

Market Overview
The global Biotherapeutics Cell Line Development market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.2% in the forecast period of 2020 to 2025 and will expected to reach USD 64590 million by 2025, from USD 54720 million in 2019.

The Biotherapeutics Cell Line Development market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Biotherapeutics Cell Line Development market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Biotherapeutics Cell Line Development market has been segmented into:
Transfection & Selection
Single Cell Cloning

By Application, Biotherapeutics Cell Line Development has been segmented into:
In-house
Outsource
Hybrid
Do-It-Yourself (DIY)

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biotherapeutics Cell Line Development market presented in the report. This section sheds light on the sales growth of different regional and country-level Biotherapeutics Cell Line Development markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biotherapeutics Cell Line Development market.

The report offers in-depth assessment of the growth and other aspects of the Biotherapeutics Cell Line Development market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Biotherapeutics Cell Line Development Market Share Analysis
Biotherapeutics Cell Line Development competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biotherapeutics Cell Line Development sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biotherapeutics Cell Line Development sales, revenue and market share for each player covered in this report.

The major players covered in Biotherapeutics Cell Line Development are:
Becton Dickinson & Company
Partec (Sysmex Corporation)
Catalent Inc.
Beckman Coulter
EMD Millipore
Boehringer Ingelheim Group
Selexis SA
Lonza Group Ltd.
CMC Biologics A/S
ProBioGen AG
Sigma-Aldrich Co. LLC.
Sony Biotechnology Inc.
Thermo Fisher Scientific Inc.

Table of Contents

1 Biotherapeutics Cell Line Development Market Overview
1.1 Product Overview and Scope of Biotherapeutics Cell Line Development
1.2 Classification of Biotherapeutics Cell Line Development by Type
1.2.1 Global Biotherapeutics Cell Line Development Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Biotherapeutics Cell Line Development Revenue Market Share by Type in 2019
1.2.3 Transfection & Selection
1.2.4 Single Cell Cloning
1.3 Global Biotherapeutics Cell Line Development Market by Application
1.3.1 Overview: Global Biotherapeutics Cell Line Development Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 In-house
1.3.3 Outsource
1.3.4 Hybrid
1.3.5 Do-It-Yourself (DIY)
1.4 Global Biotherapeutics Cell Line Development Market by Regions
1.4.1 Global Biotherapeutics Cell Line Development Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Biotherapeutics Cell Line Development (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Biotherapeutics Cell Line Development Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Biotherapeutics Cell Line Development Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biotherapeutics Cell Line Development Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Biotherapeutics Cell Line Development Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biotherapeutics Cell Line Development Status and Prospect (2015-2025)
2 Company Profiles
2.1 Becton Dickinson & Company
2.1.1 Becton Dickinson & Company Details
2.1.2 Becton Dickinson & Company Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Becton Dickinson & Company SWOT Analysis
2.1.4 Becton Dickinson & Company Product and Services
2.1.5 Becton Dickinson & Company Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2018-2019)
2.2 Partec (Sysmex Corporation)
2.2.1 Partec (Sysmex Corporation) Details
2.2.2 Partec (Sysmex Corporation) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Partec (Sysmex Corporation) SWOT Analysis
2.2.4 Partec (Sysmex Corporation) Product and Services
2.2.5 Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2018-2019)
2.3 Catalent Inc.
2.3.1 Catalent Inc. Details
2.3.2 Catalent Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Catalent Inc. SWOT Analysis
2.3.4 Catalent Inc. Product and Services
2.3.5 Catalent Inc. Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2018-2019)
2.4 Beckman Coulter
2.4.1 Beckman Coulter Details
2.4.2 Beckman Coulter Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Beckman Coulter SWOT Analysis
2.4.4 Beckman Coulter Product and Services
2.4.5 Beckman Coulter Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2018-2019)
2.5 EMD Millipore
2.5.1 EMD Millipore Details
2.5.2 EMD Millipore Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 EMD Millipore SWOT Analysis
2.5.4 EMD Millipore Product and Services
2.5.5 EMD Millipore Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2018-2019)
2.6 Boehringer Ingelheim Group
2.6.1 Boehringer Ingelheim Group Details
2.6.2 Boehringer Ingelheim Group Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Boehringer Ingelheim Group SWOT Analysis
2.6.4 Boehringer Ingelheim Group Product and Services
2.6.5 Boehringer Ingelheim Group Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2018-2019)
2.7 Selexis SA
2.7.1 Selexis SA Details
2.7.2 Selexis SA Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Selexis SA SWOT Analysis
2.7.4 Selexis SA Product and Services
2.7.5 Selexis SA Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2018-2019)
2.8 Lonza Group Ltd.
2.8.1 Lonza Group Ltd. Details
2.8.2 Lonza Group Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Lonza Group Ltd. SWOT Analysis
2.8.4 Lonza Group Ltd. Product and Services
2.8.5 Lonza Group Ltd. Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2018-2019)
2.9 CMC Biologics A/S
2.9.1 CMC Biologics A/S Details
2.9.2 CMC Biologics A/S Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 CMC Biologics A/S SWOT Analysis
2.9.4 CMC Biologics A/S Product and Services
2.9.5 CMC Biologics A/S Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2018-2019)
2.10 ProBioGen AG
2.10.1 ProBioGen AG Details
2.10.2 ProBioGen AG Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 ProBioGen AG SWOT Analysis
2.10.4 ProBioGen AG Product and Services
2.10.5 ProBioGen AG Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2018-2019)
2.11 Sigma-Aldrich Co. LLC.
2.11.1 Sigma-Aldrich Co. LLC. Details
2.11.2 Sigma-Aldrich Co. LLC. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Sigma-Aldrich Co. LLC. SWOT Analysis
2.11.4 Sigma-Aldrich Co. LLC. Product and Services
2.11.5 Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2018-2019)
2.12 Sony Biotechnology Inc.
2.12.1 Sony Biotechnology Inc. Details
2.12.2 Sony Biotechnology Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Sony Biotechnology Inc. SWOT Analysis
2.12.4 Sony Biotechnology Inc. Product and Services
2.12.5 Sony Biotechnology Inc. Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2018-2019)
2.13 Thermo Fisher Scientific Inc.
2.13.1 Thermo Fisher Scientific Inc. Details
2.13.2 Thermo Fisher Scientific Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Thermo Fisher Scientific Inc. SWOT Analysis
2.13.4 Thermo Fisher Scientific Inc. Product and Services
2.13.5 Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Biotherapeutics Cell Line Development Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Biotherapeutics Cell Line Development Players Market Share
3.2.2 Top 10 Biotherapeutics Cell Line Development Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Biotherapeutics Cell Line Development Revenue and Market Share by Regions
4.2 North America Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
4.3 Europe Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
4.5 South America Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
5 North America Biotherapeutics Cell Line Development Revenue by Countries
5.1 North America Biotherapeutics Cell Line Development Revenue by Countries (2015-2020)
5.2 USA Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
5.3 Canada Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
5.4 Mexico Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
6 Europe Biotherapeutics Cell Line Development Revenue by Countries
6.1 Europe Biotherapeutics Cell Line Development Revenue by Countries (2015-2020)
6.2 Germany Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
6.3 UK Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
6.4 France Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
6.5 Russia Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
6.6 Italy Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Biotherapeutics Cell Line Development Revenue by Countries
7.1 Asia-Pacific Biotherapeutics Cell Line Development Revenue by Countries (2015-2020)
7.2 China Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
7.3 Japan Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
7.4 Korea Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
7.5 India Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
8 South America Biotherapeutics Cell Line Development Revenue by Countries
8.1 South America Biotherapeutics Cell Line Development Revenue by Countries (2015-2020)
8.2 Brazil Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
8.3 Argentina Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Biotherapeutics Cell Line Development by Countries
9.1 Middle East & Africa Biotherapeutics Cell Line Development Revenue by Countries (2015-2020)
9.2 Saudi Arabia Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
9.3 UAE Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
9.4 Egypt Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
9.5 South Africa Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Biotherapeutics Cell Line Development Revenue and Market Share by Type (2015-2020)
10.2 Global Biotherapeutics Cell Line Development Market Forecast by Type (2019-2024)
10.3 Transfection & Selection Revenue Growth Rate (2015-2025)
10.4 Single Cell Cloning Revenue Growth Rate (2015-2025)
11 Global Biotherapeutics Cell Line Development Market Segment by Application
11.1 Global Biotherapeutics Cell Line Development Revenue Market Share by Application (2015-2020)
11.2 Biotherapeutics Cell Line Development Market Forecast by Application (2019-2024)
11.3 In-house Revenue Growth (2015-2020)
11.4 Outsource Revenue Growth (2015-2020)
11.5 Hybrid Revenue Growth (2015-2020)
11.6 Do-It-Yourself (DIY) Revenue Growth (2015-2020)
12 Global Biotherapeutics Cell Line Development Market Size Forecast (2021-2025)
12.1 Global Biotherapeutics Cell Line Development Market Size Forecast (2021-2025)
12.2 Global Biotherapeutics Cell Line Development Market Forecast by Regions (2021-2025)
12.3 North America Biotherapeutics Cell Line Development Revenue Market Forecast (2021-2025)
12.4 Europe Biotherapeutics Cell Line Development Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Biotherapeutics Cell Line Development Revenue Market Forecast (2021-2025)
12.6 South America Biotherapeutics Cell Line Development Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Biotherapeutics Cell Line Development Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

Tables and Figures

List of Tables

Table 1. Global Biotherapeutics Cell Line Development Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biotherapeutics Cell Line Development by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biotherapeutics Cell Line Development Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Biotherapeutics Cell Line Development Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Becton Dickinson & Company Corporate Information, Location and Competitors
Table 6. Becton Dickinson & Company Biotherapeutics Cell Line Development Major Business
Table 7. Becton Dickinson & Company Biotherapeutics Cell Line Development Total Revenue (USD Million) (2017-2018)
Table 8. Becton Dickinson & Company SWOT Analysis
Table 9. Becton Dickinson & Company Biotherapeutics Cell Line Development Product and Solutions
Table 10. Becton Dickinson & Company Biotherapeutics Cell Line Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Partec (Sysmex Corporation) Corporate Information, Location and Competitors
Table 12. Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Major Business
Table 13. Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Total Revenue (USD Million) (2018-2019)
Table 14. Partec (Sysmex Corporation) SWOT Analysis
Table 15. Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Product and Solutions
Table 16. Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Catalent Inc. Corporate Information, Location and Competitors
Table 18. Catalent Inc. Biotherapeutics Cell Line Development Major Business
Table 19. Catalent Inc. Biotherapeutics Cell Line Development Total Revenue (USD Million) (2017-2018)
Table 20. Catalent Inc. SWOT Analysis
Table 21. Catalent Inc. Biotherapeutics Cell Line Development Product and Solutions
Table 22. Catalent Inc. Biotherapeutics Cell Line Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Beckman Coulter Corporate Information, Location and Competitors
Table 24. Beckman Coulter Biotherapeutics Cell Line Development Major Business
Table 25. Beckman Coulter Biotherapeutics Cell Line Development Total Revenue (USD Million) (2017-2018)
Table 26. Beckman Coulter SWOT Analysis
Table 27. Beckman Coulter Biotherapeutics Cell Line Development Product and Solutions
Table 28. Beckman Coulter Biotherapeutics Cell Line Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. EMD Millipore Corporate Information, Location and Competitors
Table 30. EMD Millipore Biotherapeutics Cell Line Development Major Business
Table 31. EMD Millipore Biotherapeutics Cell Line Development Total Revenue (USD Million) (2017-2018)
Table 32. EMD Millipore SWOT Analysis
Table 33. EMD Millipore Biotherapeutics Cell Line Development Product and Solutions
Table 34. EMD Millipore Biotherapeutics Cell Line Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Boehringer Ingelheim Group Corporate Information, Location and Competitors
Table 36. Boehringer Ingelheim Group Biotherapeutics Cell Line Development Major Business
Table 37. Boehringer Ingelheim Group Biotherapeutics Cell Line Development Total Revenue (USD Million) (2017-2018)
Table 38. Boehringer Ingelheim Group SWOT Analysis
Table 39. Boehringer Ingelheim Group Biotherapeutics Cell Line Development Product and Solutions
Table 40. Boehringer Ingelheim Group Biotherapeutics Cell Line Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Selexis SA Corporate Information, Location and Competitors
Table 42. Selexis SA Biotherapeutics Cell Line Development Major Business
Table 43. Selexis SA Biotherapeutics Cell Line Development Total Revenue (USD Million) (2017-2018)
Table 44. Selexis SA SWOT Analysis
Table 45. Selexis SA Biotherapeutics Cell Line Development Product and Solutions
Table 46. Selexis SA Biotherapeutics Cell Line Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Lonza Group Ltd. Corporate Information, Location and Competitors
Table 48. Lonza Group Ltd. Biotherapeutics Cell Line Development Major Business
Table 49. Lonza Group Ltd. Biotherapeutics Cell Line Development Total Revenue (USD Million) (2017-2018)
Table 50. Lonza Group Ltd. SWOT Analysis
Table 51. Lonza Group Ltd. Biotherapeutics Cell Line Development Product and Solutions
Table 52. Lonza Group Ltd. Biotherapeutics Cell Line Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. CMC Biologics A/S Corporate Information, Location and Competitors
Table 54. CMC Biologics A/S Biotherapeutics Cell Line Development Major Business
Table 55. CMC Biologics A/S Biotherapeutics Cell Line Development Total Revenue (USD Million) (2017-2018)
Table 56. CMC Biologics A/S SWOT Analysis
Table 57. CMC Biologics A/S Biotherapeutics Cell Line Development Product and Solutions
Table 58. CMC Biologics A/S Biotherapeutics Cell Line Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. ProBioGen AG Corporate Information, Location and Competitors
Table 60. ProBioGen AG Biotherapeutics Cell Line Development Major Business
Table 61. ProBioGen AG Biotherapeutics Cell Line Development Total Revenue (USD Million) (2017-2018)
Table 62. ProBioGen AG SWOT Analysis
Table 63. ProBioGen AG Biotherapeutics Cell Line Development Product and Solutions
Table 64. ProBioGen AG Biotherapeutics Cell Line Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Sigma-Aldrich Co. LLC. Corporate Information, Location and Competitors
Table 66. Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Major Business
Table 67. Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Total Revenue (USD Million) (2017-2018)
Table 68. Sigma-Aldrich Co. LLC. SWOT Analysis
Table 69. Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Product and Solutions
Table 70. Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Sony Biotechnology Inc. Corporate Information, Location and Competitors
Table 72. Sony Biotechnology Inc. Biotherapeutics Cell Line Development Major Business
Table 73. Sony Biotechnology Inc. Biotherapeutics Cell Line Development Total Revenue (USD Million) (2017-2018)
Table 74. Sony Biotechnology Inc. SWOT Analysis
Table 75. Sony Biotechnology Inc. Biotherapeutics Cell Line Development Product and Solutions
Table 76. Sony Biotechnology Inc. Biotherapeutics Cell Line Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Thermo Fisher Scientific Inc. Corporate Information, Location and Competitors
Table 78. Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Major Business
Table 79. Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Total Revenue (USD Million) (2017-2018)
Table 80. Thermo Fisher Scientific Inc. SWOT Analysis
Table 81. Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Product and Solutions
Table 82. Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global Biotherapeutics Cell Line Development Revenue (Million USD) by Players (2015-2020)
Table 84. Global Biotherapeutics Cell Line Development Revenue Share by Players (2015-2020)
Table 85. Global Biotherapeutics Cell Line Development Revenue (Million USD) by Regions (2015-2020)
Table 86. Global Biotherapeutics Cell Line Development Revenue Market Share by Regions (2015-2020)
Table 87. North America Biotherapeutics Cell Line Development Revenue by Countries (2015-2020)
Table 88. North America Biotherapeutics Cell Line Development Revenue Market Share by Countries (2015-2020)
Table 89. Europe Biotherapeutics Cell Line Development Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific Biotherapeutics Cell Line Development Revenue (Million USD) by Countries (2015-2020)
Table 91. South America Biotherapeutics Cell Line Development Revenue by Countries (2015-2020)
Table 92. South America Biotherapeutics Cell Line Development Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Biotherapeutics Cell Line Development Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa Biotherapeutics Cell Line Development Revenue Market Share by Countries (2015-2020)
Table 95. Global Biotherapeutics Cell Line Development Revenue (Million USD) by Type (2015-2020)
Table 96. Global Biotherapeutics Cell Line Development Revenue Share by Type (2015-2020)
Table 97. Global Biotherapeutics Cell Line Development Revenue Forecast by Type (2021-2025)
Table 98. Global Biotherapeutics Cell Line Development Revenue by Application (2015-2020)
Table 99. Global Biotherapeutics Cell Line Development Revenue Share by Application (2015-2020)
Table 100. Global Biotherapeutics Cell Line Development Revenue Forecast by Application (2021-2025)
Table 101. Global Biotherapeutics Cell Line Development Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Biotherapeutics Cell Line Development Picture
Figure 2. Global Biotherapeutics Cell Line Development Revenue Market Share by Type in 2019
Figure 3. Transfection & Selection Picture
Figure 4. Single Cell Cloning Picture
Figure 5. Biotherapeutics Cell Line Development Revenue Market Share by Application in 2019
Figure 6. In-house Picture
Figure 7. Outsource Picture
Figure 8. Hybrid Picture
Figure 9. Do-It-Yourself (DIY) Picture
Figure 10. Global Biotherapeutics Cell Line Development Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Biotherapeutics Cell Line Development Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Biotherapeutics Cell Line Development Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Biotherapeutics Cell Line Development Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Biotherapeutics Cell Line Development Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Biotherapeutics Cell Line Development Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Biotherapeutics Cell Line Development Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Biotherapeutics Cell Line Development Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Biotherapeutics Cell Line Development Revenue Market Share in 2019
Figure 19. Global Top 10 Players Biotherapeutics Cell Line Development Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Biotherapeutics Cell Line Development Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Biotherapeutics Cell Line Development Revenue Market Share by Regions (2015-2020)
Figure 23. Global Biotherapeutics Cell Line Development Revenue Market Share by Regions in 2018
Figure 24. North America Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
Figure 25. Europe Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
Figure 27. South America Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
Figure 29. North America Biotherapeutics Cell Line Development Revenue Market Share by Countries (2015-2020)
Figure 30. North America Biotherapeutics Cell Line Development Revenue Market Share by Countries in 2019
Figure 31. USA Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
Figure 32. Canada Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
Figure 34. Europe Biotherapeutics Cell Line Development Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Biotherapeutics Cell Line Development Revenue Market Share by Countries in 2019
Figure 36. Germany Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
Figure 37. UK Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
Figure 38. France Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
Figure 39. Russia Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
Figure 40. Italy Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Biotherapeutics Cell Line Development Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Biotherapeutics Cell Line Development Revenue Market Share by Countries in 2019
Figure 43. China Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
Figure 44. Japan Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
Figure 45. Korea Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
Figure 46. India Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
Figure 48. South America Biotherapeutics Cell Line Development Revenue Market Share by Countries (2015-2020)
Figure 49. South America Biotherapeutics Cell Line Development Revenue Market Share by Countries in 2019
Figure 50. Brazil Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Biotherapeutics Cell Line Development Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Biotherapeutics Cell Line Development Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
Figure 55. UAE Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Biotherapeutics Cell Line Development Revenue and Growth Rate (2015-2020)
Figure 58. Global Biotherapeutics Cell Line Development Revenue Share by Type (2015-2020)
Figure 59. Global Biotherapeutics Cell Line Development Revenue Share by Type in 2019
Figure 60. Global Biotherapeutics Cell Line Development Market Share Forecast by Type (2021-2025)
Figure 61. Global Transfection & Selection Revenue Growth Rate (2015-2020)
Figure 62. Global Single Cell Cloning Revenue Growth Rate (2015-2020)
Figure 63. Global Biotherapeutics Cell Line Development Revenue Share by Application (2015-2020)
Figure 64. Global Biotherapeutics Cell Line Development Revenue Share by Application in 2019
Figure 65. Global Biotherapeutics Cell Line Development Market Share Forecast by Application (2021-2025)
Figure 66. Global In-house Revenue Growth Rate (2015-2020)
Figure 67. Global Outsource Revenue Growth Rate (2015-2020)
Figure 68. Global Hybrid Revenue Growth Rate (2015-2020)
Figure 69. Global Do-It-Yourself (DIY) Revenue Growth Rate (2015-2020)
Figure 70. Global Biotherapeutics Cell Line Development Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Biotherapeutics Cell Line Development Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Biotherapeutics Cell Line Development Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Biotherapeutics Cell Line Development Revenue Market Forecast (2021-2025)
Figure 74. Europe Biotherapeutics Cell Line Development Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Biotherapeutics Cell Line Development Revenue Market Forecast (2021-2025)
Figure 76. South America Biotherapeutics Cell Line Development Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Biotherapeutics Cell Line Development Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel




Companies Mentioned
Becton Dickinson & Company
Partec (Sysmex Corporation)
Catalent Inc.
Beckman Coulter
EMD Millipore
Boehringer Ingelheim Group
Selexis SA
Lonza Group Ltd.
CMC Biologics A/S
ProBioGen AG
Sigma-Aldrich Co. LLC.
Sony Biotechnology Inc.
Thermo Fisher Scientific Inc.

Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets